Sakar Healthcare P/B Ratio
Sakar Healthcare (SAKAR) P/B ratio is 5.39 (High), book value per share ₹147.73 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Compare with SAKAR fundamental valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SAKAR P/B Ratio — Valuation Insights & Book Value Analysis
Sakar Healthcare price-to-book ratio interpretation, valuation status and historical context — current P/B 5.39 (High). View SAKAR 52-week chart for the annual high/low range and current price position.
- Stock appears overvalued with PB of 5.39, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 27.0% above historical average
- Trading at premium to sector average PB of -0.33
Sakar Healthcare P/B Ratio Historical Trend
SAKAR annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Sakar Healthcare screener.
SAKAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Sakar Healthcare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 5.34 | ₹147.73 | ₹788.25 | ₹325 | High |
| 2025 | 3.15 | ₹130.0 | ₹409.20 | ₹286 | High |
SAKAR vs Healthcare Peers — P/B Ratio Comparison
Sakar Healthcare P/B 5.39 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |